Medication Updates

Industry Targeted Insight

Amjevita

First biosimilar for Humira® now available

Medication Update / Amjevita™

Click Here to View Paper
Brenzavvy2

New SGLT2 inhibitor for Diabetes Type 2

Medication Update / Brenzavvy

Click Here to View Paper
Jesduvroq 2

New Oral Option for patient with Anemia due to CKD on Dialysis

Medication Update / Jesduvroq

Click Here to View Paper
Medication Update_004_Aflibercept

New Biosimilar for Macular Degeneration and Retinopathy

Medication Update / Aflibercept (Eylea)

Click Here to View Paper

Need help?

PayerAlly’s mission is to provide pharmacy consulting services to our clients in an impartial manner enabling them to make better decisions, lower overall medication costs, and better plan for future high-cost, life-changing medications.

Contact PayerAlly